ArticleCureus2026
Awareness Level of Herpes Zoster Infection Among the Residents of Jeddah, Saudi Arabia.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHerpes zoster (HZ), also known as shingles, is a viral infection caused by the reactivation of the varicella-zoster virus. Awareness and knowledge of HZ and its associated complications vary across countries. Limited data are available on the awareness and knowledge of HZ among the general population in Saudi Arabia. Therefore, this study aims to measure awareness of HZ infection and its vaccine among the citizens of Jeddah, Saudi Arabia.
methodsAn online questionnaire was distributed to the citizens of Jeddah, Saudi Arabia, to assess their awareness and knowledge of HZ. The questionnaire included demographic characteristics, awareness of HZ and its vaccine, and knowledge about both HZ and the HZ vaccine. Descriptive statistics and logistic regression analysis were used to analyze the data.
resultsA total of 557 valid responses were included in the analysis. The majority were female participants (79%) and Saudi nationals (94.8%). The awareness level of HZ was high, with 85.1% of participants reporting having heard of it. However, only 34.2% were aware of the HZ vaccine. The knowledge level regarding HZ and its vaccine varied, with some misconceptions observed. Factors associated with HZ vaccination included age, family history of HZ, and awareness of HZ. Participants with a family history of HZ had higher odds of vaccination (OR: 4.2, p = 0.002).
conclusionThis study revealed moderate awareness and knowledge of HZ and its vaccine among citizens of Jeddah, Saudi Arabia. Improving knowledge about HZ and its vaccine can contribute to the prevention and management of this viral infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.